The three-year award from the National Institute for Health and Care Research will support finalization of the test as well as initial validation studies.

Last week, readers were most interested in a story about the FDA's decision not to appeal a court decision vacating the agency's LDT rule.

The test is the last of three multiplex bloodstream infection panels that the firm has designed for its Liaison Plex molecular testing instrument.

NEW YORK – New data published in JAMA Internal Medicine on Friday from MD Anderson Cancer Center researchers found that mail-in self-collection kits for human papillomavirus testing more than doubled ...

NEW YORK – Lex Diagnostics announced Friday that it has submitted its point-of-care molecular diagnostics system along with a test to detect influenza A, influenza B, and COVID-19 to the US Food and ...

The firm is maintaining its full-year guidance and expects to make the acquisition once Lex Diagnostics obtains 510(k) clearance of its system.

Multiple presentations at the meeting discussed the utility of circulating tumor DNA to guide treatment for colorectal cancer.

The Randox ConcizuTrace ELISA is used to determine the concentration in blood of Novo Nordisk's Alhemo (concizumab-mtci) to aid dose adjustments.

Company officials disclosed that it had been eyeing an out from Savanna in the potential acquisition of Lex Diagnostics for at least the past 18 months.

NEW YORK – Canadian researchers have developed a point-of-care molecular blood test to quickly predict which patients in the emergency department or ICU are likely to develop sepsis within 24 hours.